Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α

Journal of Experimental Medicine

Volumn 166, Issue 4, 1987, Pages 991-998

  Ranges, Gerald E ^a   Figari, Irene S ^a   Espevik, Terje ^a   Palladino, Michael A ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CYTOTOXIC T LYMPHOCYTE; NONHUMAN;

ANIMAL; ANTIBODIES; FEMALE; KINETICS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDES; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTOR;

EID: 0023583780     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.166.4.991     Document Type: Article

References (22)

1. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and R. K. Assoian. 1986. Transforming growth factor-β: Biological function and chemical structure. Science (Wash. DC). 233:532.
2. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor j8 by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
3. Ristow, H.J. 1986. BSC-1 growth inhibitor 1 type B transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc. Natl. Acad. Sci. USA. 83:5531.
4. Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci. Transforming growth factor-β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855.
5. Palladino, M. A., C. W. Czarniecki, H. H. Chiu, S. M. McCabe, I. S. Figari, and A. J. Ammann. 1986. Regulation of cytokine production and class II antigen expression by transforming growth factor-beta. UCLA Symp. Growth Factors. In press.
6. Espevik, T., I. S. Figari, M. R. Shalaby, G. A. Lackides, G. D. Lewis, H. M. Shepard, and M. A. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166:571.
7. Sugarman, B. J., B. B. Aggarwal, P. E. Haas, I. S. Figari, M. A. Palladino, and H. M. Shepard. 1985. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science (Wash. DC). 230:943.
8. Abbott, J., P. J. Doyle, K. Ngiam, and C. L. Olson. 1981. Ontogeny of murine lymphocytes I. Maturation of thymocytes induced in vitro by tumor necrosis factor-positive serum (TNF). Cell Immunol. 57:237.
9. Ramila, P., and L. B. Epstein. 1986. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature (Lond.). 323:86.
10. Scheurich, P., B. Thoma, U. Ulcer, and K. Pfizenmaier. 1987. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF) -α: induction of TNF receptors on human T cells and TNF-a mediated enhancement of T cell responses. J. Immunol. 138:1786.
11. Pennica, D., J. S. Hayflick, T. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Cloning and expression in E. coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 82:6060.
12. Kramer, S. M., and M. E. Carver. 1986. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods. 93:210.
13. Pennica, D., G. E. Nedwin.J. S. Hayflick, P. H. Seeburg, R. Derynck, M. A. Palladino, W.J. Kohr, B. B. Aggarwal, D. V. Goeddel. 1984. Human tumor necrosis factor: cDNA cloning, expression and homology to lymphotoxin. Nature (Lond.). 312:724.
14. Gray, P. W., B. B. Aggarwal, C. V. Benton, T. S. Bringman, W. J. Henzel, J. A. Jarrett, D. W. Leung, B. Moffat, P. Ng, L. P. Svedersky, M. A. Palladino, and G. E. Nedwin. 1984. Cloning and expression of cDNA for human lymphotoxin, a lympho-kine with tumor necrosis activity. Nature (Lond.). 312:721.
15. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI-164, clone 13, for measuring cytotoxic factorβumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99.
16. Peters, P. M., J. R. Ortaldo, M. R. Shalaby, L. P. Svedersky, G. E. Nedwin, T. S. Bringman, P. E. Hass, B. B. Aggarwal, R. B. Herberman, D. V. Goeddel, and M. A. Palladino, Jr. 1986. Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human large granular lymphocytes. J. Immunol. 137:2592.
17. Derynck, R., and L. Rhee. 1987. Sequence of the porcine transforming growth factor-beta precursor. Nucleic Acids Res. 15:3187.
18. Mannel, D. N., W. Falk, and W. Droge. 1983. Induction of cytotoxic T cell function requires sequential action of three different lymphokines. J. Immunol. 130:2508.
19. Gately, M. K., D. E. Wilson, and H. L. Wong. 1986. Synergy between recombinant interleukin-2 (rIL-2) and IL-2 depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro. J. Immunol. 136:1274.
20. Yang, S. S., T. R. Malek, M. E. Hargrove, and C. C. Ting. 1985. Lymphokine induced cytotoxicity: Requirement of two lymphokines for the induction of optimal cytotoxic responses. J. Immunol. 134:3912.
21. Kanagawa, O., and J. M. Chiller. 1985. Lymphokine-mediated induction of cytotoxic activity in a T cell hybridoma. J. Immunol. 134:397.
22. Nedwin, G. E., L. P. Svedersky, T. S. Bringman, M. A. Palladino, Jr., and D. V. Goeddel. 1985. Effect of interleukin-2, interferon-γ, and mitogens on the production of tumor necrosis factors α and β. J. Immunol. 135:2492.